Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)
India · Delayed Price · Currency is INR 133.41
+3.39 (2.61%)
At close: Jul 14, 2026
NSE:GAUDIUMIVF Revenue
In the fiscal year ending March 31, 2026, Gaudium IVF and Women Health had annual revenue of 1.04B INR with 47.56% growth. Gaudium IVF and Women Health had revenue of 303.51M in the quarter ending March 31, 2026, with 91.54% growth.
Revenue
1.04B
Revenue Growth
+47.56%
P/S Ratio
9.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.71B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.04B | 336.33M | 47.56% |
| Mar 31, 2025 | 707.24M | 228.34M | 47.68% |
| Mar 31, 2024 | 478.90M | 36.35M | 8.21% |
| Mar 31, 2023 | 442.55M | 77.36M | 21.18% |
| Mar 31, 2022 | 365.20M | 303.45M | 491.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IFB Agro Industries | 14.04B |
| Arisinfra Solutions | 10.67B |
| Scoda Tubes | 5.19B |
| Matrimony.com | 4.60B |
| Stanley Lifestyles | 4.19B |
| Royal Orchid Hotels | 3.84B |
| Bombay Super Hybrid Seeds | 3.44B |
| Krishival Foods | 2.93B |